1Santin AD, Zhan f, Bellone S, et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy[J] .Int J Cancer,2004,112:14.
3Lu KH,Patterson AP, Wang L,et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis[J]. Clin Cancer Res,2004,10:3291.
4Drapkin R, yon Horsten HH, Lin Y, et al. Human epididymis protein4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[ J ]. Cancer Res, 2005,65: 2162.
5Adib TR, Henderson S,Perrett C,et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays[J]. Br J Cancer, 2004, 90(3) : 686.
6Collins Y, Tan DF, Pejovic T, et al. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray[J], Int J Mol Med, 2004,14( 1 ) :43.
7Hibbs K,Skubitz KM, Pambuccian SE,et al. Differential gene expression in ovarian carcinoma: identification of potential biomarkers [ J ]. Am Jpathol, 2004,165(2) : 397.
8Lee BC, Cha K, Avraham S, et al. Microarray analysis of differentially expressed genes associated with human ovarian cancer[J]. Int J Oncon, 2004,24(4) :847.
9Huddleston HG,Wong KK, Welch WR,et al. Clinical applications of microarray technology:creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker[J]. Gynecol Oncol, 2005,96(1) :77.
10Konno R. Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray[J], hum Cell, 2001,14:261.
